OR-LATTICE-SEMICONDUCTOR
12.8.2020 22:02:08 CEST | Business Wire | Press release
Lattice Semiconductor Corporation (NASDAQ: LSCC), the low power programmable leader, today launched the Lattice Sentry™ solutions stack and the Lattice SupplyGuard™ supply chain protection service. The Sentry stack is a robust combination of customizable embedded software, reference designs, IP, and development tools to accelerate the implementation of secure systems compliant with NIST Platform Firmware Resiliency (PFR) Guidelines (NIST SP-800-193). The Lattice SupplyGuard service extends the system protection provided by the Sentry stack throughout today’s challenging and rapidly changing supply chain by delivering factory-locked devices to protect them from attacks like cloning and malware insertion, and enables secure device ownership transfer. These hardware security solutions are increasingly important to a range of applications, including communications, datacenter, industrial, automotive, aerospace, and client computing.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200812005214/en/
According to Patrick Moorhead, president and founder of Moor Insights & Strategy, “5G, Edge computing, and IoT are accelerating the pace at which devices are becoming connected, and security concerns are on the rise among high-tech OEMs serving every market. Developers need to know their hardware platforms are secured against cyberattack and IP theft. They need security solutions that support comprehensive protection throughout a product’s entire operating life in the field, which means the solution must be able to dynamically adapt to an evolving threat landscape.”
“Lattice continues to execute to our solutions stack roadmap and strategy to provide our customers with easy to use, system-level solutions for key focus applications. The Lattice Sentry solutions stack makes it easy for customers to implement a hardware Root-of-Trust (RoT)-based PFR solution compliant with the NIST SP-800-193 guidelines,” said Deepak Boppana, Sr. Director, Segments and Solutions Marketing, Lattice. “With Sentry’s validated IPs, pre-verified reference designs, and hardware demos, developers can quickly customize the PFR solution by modifying the C code provided with the RISC-V and Propel design environment to cut time-to-market from ten months to just six weeks.”
The security paradigm is changing, and firmware is an increasingly popular attack vector. The National Vulnerability Database reported that between 2016 and 2019 the number of firmware vulnerabilities grew over 700 percent1 . Protecting systems against unauthorized firmware access requires dynamic, persistent, real-time hardware platform security for all connected devices. This includes securing component firmware from unauthorized access and enabling the system to automatically protect, detect, and recover from an attack in an instant. TPM and MCU-based hardware security solutions use serial processing and cannot deliver the real-time performance that parallel processing solutions like Lattice FPGAs can.
“To provide them with peace of mind in a constantly changing and increasingly risky supply chain environment, Lattice developed our SupplyGuard service to help our customers securely provision their devices while lowering their overall costs,” said Eric Sivertson, Vice President of Security Business, Lattice. “With Sentry and SupplyGuard, Lattice delivers comprehensive, truly parallel, nanosecond reactive, next-generation security to enable dynamic trust for our customers and the users of their products.”
Key features of the Lattice Sentry solutions stack include:
- Hardware security capabilities – the Sentry solutions stack provides a pre-verified, NIST-compliant PFR implementation that enforces strict, real-time access controls to all system firmware during and after system boot. If corrupt firmware is detected, Sentry can automatically rollback to a previously known good state version of the firmware so secure system operation continues without interruption.
- Compliance with latest NIST SP-800-193 standard and CAVP certifications – the stack enables implementation of a hardware RoT through its support for the cryptographically-sound Lattice MachXO3D™ family of FPGAs.
- Ease of use – developers can drag-and-drop Sentry’s validated IPs and modify the included RISC-V C reference code in the Lattice Propel design environment without any prior FPGA experience.
- Rapid time-to-market – the Sentry stack provides pre-verified and tested application demos, reference designs, and development boards that can slash development times for PFR applications from ten months to just six weeks.
- Flexible, platform-agnostic security solution – Sentry offers comprehensive, real-time PFR support for firmware and programmable peripherals. It can act as a RoT in a system and/or complement any existing BMC/MCU/TPM-based architecture for full NIST SP-800-193 compliance.
Key features of the Lattice SupplyGuard supply chain protection service include:
-
Robust security throughout device lifecycle – SupplyGuard is a subscribed service that offers OEMs and ODMs peace of mind by tracking locked Lattice FPGAs through their entire lifecycle, from the point of manufacture, through transport through the global supply chain, system integration and assembly, initial configuration, and deployment. SupplyGuard helps protect OEMs by:
- Ensuring only authorized manufacturers can build an OEM’s design, regardless of their location.
- Providing OEMs with a secure key infrastructure to prevent the activation of their IP on unauthorized components to stop product cloning and overbuilding.
- Securing devices against the download and installation of Trojans, malware, or other unauthorized software to protect platforms and systems against equipment hijacking or other cyberattacks.
- Flexible, low-cost implementation – SupplyGuard is highly customizable to meet the specific security and supply chain needs of OEMs in every industry Lattice serves. The service lowers the operating costs associated with implementing a secure manufacturing ecosystem.
For more information, please visit www.latticesemi.com/LatticeSentry and www.latticesemi.com/LatticeSupplyGuard
About Lattice Semiconductor
Lattice Semiconductor (NASDAQ: LSCC) is the low power programmable leader. We solve customer problems across the network, from the Edge to the Cloud, in the growing communications, computing, industrial, automotive, and consumer markets. Our technology, long-standing relationships, and commitment to world-class support lets our customers quickly and easily unleash their innovation to create a smart, secure and connected world.
For more information about Lattice, please visit www.latticesemi.com . You can also follow us via LinkedIn , Twitter , Facebook , YouTube , WeChat , Weibo or Youku .
Lattice Semiconductor Corporation, Lattice Semiconductor (& design) and specific product designations are either registered trademarks or trademarks of Lattice Semiconductor Corporation or its subsidiaries in the United States and/or other countries. The use of the word “partner” does not imply a legal partnership between Lattice and any other entity.
GENERAL NOTICE: Other product names used in this publication are for identification purposes only and may be trademarks of their respective holders.
1 Source: National Vulnerability Database (2016 and 2019 )
View source version on businesswire.com: https://www.businesswire.com/news/home/20200812005214/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Altasciences Supports 4B Healthcare in Advancing Steroid Nasal Irrigation Rinse to Clinical Trials24.9.2026 14:40:00 CEST | Press release
Altasciences is proud to announce that recent formulation work supporting 4B Healthcare Inc. (“4B”) has helped advance its RhineX nasal irrigation rinse therapy into clinical investigation. Following several months of formulation development, R&D manufacturing, stability testing, and quality assurance support at Altasciences’ CDMO facility in Harleysville, PA, the Tennessee-based pharmaceutical company has received FDA clearance to proceed with clinical testing of RhineX under its IND. First subject dosing is planned for October 2026, approximately seven months after formulation development began. "The concept for RhineX grew out of a problem I have seen in my own ENT practice for years—the need for a better treatment option for allergic rhinitis when conventional medical therapy is not enough,” said Brannon Mangus, MD, Co-Founder and CEO of 4B. “We founded 4B Healthcare to take that physician insight and turn it into a pharmaceutical product that could meaningfully change how these pa
ParaScript Acquired by Stakk to Create a Global Digital Trust Platform Focused on Combating Fraud24.9.2026 14:30:00 CEST | Press release
ParaScript’s AI-powered document intelligence technology integrates with Stakk’s SaaS platform to provide regulated organizations with a stronger defense against AI-driven digital identity fraud.Complementary technologies establish digital trust by continuously assessing identity, documents, behavior and context, making explainable decisions in milliseconds.Combined businesses serve more than 300 enterprise customers and processes more than 110 billion digital interactions annually across the U.S., Europe, the Middle East and Australia. ParaScript, an Al-powered document processing company, today announced that Stakk Limited (ASX: SKK) (“Stakk”), a company publicly traded on the Australian Stock Exchange (ASX), has successfully completed its US$63 million (A$88.7 million) acquisition of ParaScript, LLC and ParaScript Management, Inc. (“ParaScript”), creating a scaled and profitable AI-native digital trust platform. Stakk acquired ParaScript for its industry-leading AI-powered document
SLB Awarded Four Multi-Year Integrated Well Construction Contracts by Aramco24.9.2026 14:04:00 CEST | Press release
Awards expand deployment of SLB's integrated well construction model across Saudi Arabia’s oil and gas reservoirs Global energy technology company SLB (NYSE: SLB) today announced it has been awarded four integrated well construction contracts by Aramco to support oil and gas development across the Kingdom of Saudi Arabia. Under the contracts, SLB will manage end-to-end well construction services, delivering more than 450 wells in the three-year term, with an optional extension of up to two years. "Delivering hundreds of wells across a multi-year program and in multiple operating environments requires an integrated model that connects planning, execution, and digital workflows to set new industry performance benchmarks,” said Steve Gassen, executive vice president of Geographies for SLB. “Awarding SLB these advanced well construction programs at scale reflects Aramco’s confidence in our integrated model and capabilities." SLB's integrated well construction model brings together every as
Sahajanand Medical Technologies Receives EU MDR Certification for Supraflex Cruz and Product Family, Reinforcing Global Compliance and Patient Safety24.9.2026 14:03:00 CEST | Press release
Sahajanand Medical Technologies Limited (SMT), a leading global manufacturer of cardiovascular medical devices, today announced that it has received certification under the European Union Medical Device Regulation (EU MDR 2017/745) for Supraflex Cruz and its product family. SMT is a leading player in India’s drug-eluting stent market and ranks among the top five companies in key European markets, including Germany, Spain and Poland. The certification follows the conformity assessment process established under EU MDR 2017/745 including assessment of SMT’s technical documentation, clinical evaluation and quality management system. Together with SMT’s existing ISO 13485 quality management system and MDSAP certifications, the EU MDR certification confirms that Supraflex Cruz has successfully undergone assessment against the EU MDR’s stringent requirements for safety, performance and clinical evidence. Supraflex Cruz is a sirolimus-eluting coronary stent system designed to improve luminal d
Acadia Pharmaceuticals Announces Phase 3 Enabling Topline Results from Phase 2 RADIANT Study of Remlifanserin for the Treatment of Alzheimer’s Disease Psychosis (ADP)24.9.2026 13:00:00 CEST | Press release
-- Meaningful and consistent efficacy trends across endpoints support continuing with Phase 3 development of 60 mg once daily remlifanserin in ADP, with demonstrated evidence of dose effect-- Narrowly missed primary endpoint of SAPS H+D (p=0.0603) with significance (nominal) on key secondary endpoint of CGI-S-ADP (p=0.0077)-- Favorable safety and tolerability profile across both doses-- Detailed results to be presented at upcoming Clinical Trials on Alzheimer's Disease (CTAD) conference in November-- Conference call and webcast to be held today at 8:00 a.m. Eastern Time Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced Phase 3 enabling topline results from the Phase 2 portion of the ongoing RADIANT clinical trial program evaluating remlifanserin for the treatment of hallucinations and delusions associated with Alzheimer’s disease psychosis (ADP). For the primary endpoint of change from baseline in the Scale for the Assessment of Positive Symptoms-Hallucinations and Delusions s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
